People may receive vaccine at any time before or after anti-D immunoglobulin.Anti-D immunoglobulin does not interfere with the antibody response to the vaccine.Sensitivity varies by assay and clinical setting (including time since vaccination).
Breastfeeding women can receive See Vaccination for people who are immunocompromised for more details.
For more details on using live attenuated vaccines in people receiving corticosteroid therapy, see Table.
However, this dose needs to be repeated, meaning that these infants need 2 further doses of measles-containing vaccine.
They should receive the next dose of Serological testing for immunity to measles (and mumps, rubella and varicella) is not recommended before or after routine administration of the 2-dose childhood schedule of these vaccines.
People who work in long-term care facilities are strongly recommended to have received 2 doses of measles-containing vaccine given at least 4 weeks apart.
People who work in long-term care facilities do not need to receive measles-containing vaccine if they have either: See Serological testing for immunity to measles, and Recommended vaccines for people at increased risk of certain occupationally acquired vaccine-preventable diseases in Vaccinations for people at occupational risk.People who have received an immunoglobulin-containing blood product should wait 3–11 months before receiving a measles-containing vaccine.This is because the immunoglobulin may impair the expected immune response to the vaccine. Recommended intervals between immunoglobulins or blood products, and measles-mumps-rubella, measles-mumps-rubella-varicella or varicella vaccination and Vaccination for people who have recently received normal human immunoglobulin and other blood products.Recommended timing of live attenuated vaccine doses in adults and children taking corticosteroids in Vaccination for people who are immunocompromised.A recent blood transfusion with washed red blood cells is not a contraindication to vaccines.People who have received a measles-containing vaccine should not receive immunoglobulin-containing products for 3 weeks after vaccination, unless the benefits of receiving the blood product outweigh the benefits of vaccination.If the person receives an immunoglobulin-containing product within 3 weeks after a measles-containing vaccine, the vaccinated person should be either: See also Vaccination for people who are immunocompromised.People born before 1966 do not need to receive measles-containing vaccine (unless serological evidence indicates that they are not immune).This is because circulating measles virus and disease were prevalent before 1966, so most people would have acquired immunity from natural infection.See Catch-up vaccination for more details, including minimum intervals between doses.Adolescents and adults who have been incompletely vaccinated or do not have evidence of immunity to measles are recommended to receive measles-containing vaccine.